公告
$A.P.制药(APPA)$ 8-K - Current report Filed: 2019-10-28 AccNo: 0001564590-19-038027 Size: 215 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
简介:Heron Therapeutics, Inc.是一家专业制药公司,利用其专有的Biochronomer以聚合物为基础的药物输送技术开发医药产品。该公司的主要重点是其领先候选产品,APF530,该产品是为用于预防化疗引起的恶心和呕吐(CINV)而开发。该公司的核心Biochronomer技术包括旨在规定时间内释放药物的可生物腐蚀聚合物,其APF530和其他候选产品都是基于该技术而研发。该公司已完成100多项体内和体外研究,研究结果表明,该公司的Biochronomer技术可能适用于多种治疗领域,包括预防恶心和呕吐,疼痛管理,炎症的控制与眼科疾病的治疗。该公司还完成了全面的动物和人体毒理学研究,并得出结论——其Biochronomer聚合物是安全的,并具有良好的耐受性。此外,该公司的Biochronomer技术可以用于在几天或几个月内释放药物。该公司于1983年2月在加利福尼亚州成立,当时的名称为AMCO Polymerics公司(AMCO)。AMCO公司于1984年更名为Advanced Polymer Systems公司,并于1987年在特拉华州重新合并成立。该公司于2001年5月更名为AP制药公司,以反映其新的药品重点。
今开: | 昨收: |
最高: | 最低: |
涨停价: | 跌停价: |
总市值:202920000 |
$A.P.制药(APPA)$ 8-K - Current report Filed: 2019-10-28 AccNo: 0001564590-19-038027 Size: 215 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$A.P.制药(APPA)$ 8-K - Current report Filed: 2019-10-22 AccNo: 0001564590-19-037287 Size: 230 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$A.P.制药(APPA)$ 8-K - Current report Filed: 2019-10-08 AccNo: 0001193125-19-264451 Size: 461 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$A.P.制药(APPA)$ 424B2 - Prospectus [Rule 424(b)(2)] Filed: 2019-10-07 AccNo: 0001193125-19-263773 Size: 356 KB 网页链接
$A.P.制药(APPA)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-10-03 AccNo: 0001193125-19-261632 Size: 355 KB 网页链接
$A.P.制药(APPA)$ 8-K - Current report Filed: 2019-10-02 AccNo: 0001564590-19-036139 Size: 20 MBItem 7.01: Regulation FD DisclosureItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$A.P.制药(APPA)$ 8-K - Current report Filed: 2019-10-01 AccNo: 0001564590-19-036000 Size: 210 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$A.P.制药(APPA)$ 8-K - Current report Filed: 2019-10-01 AccNo: 0001564590-19-036090 Size: 214 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financial Sta...
$A.P.制药(APPA)$ 8-K - Current report Filed: 2019-10-01 AccNo: 0001564590-19-036093 Size: 192 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financial Sta...
$A.P.制药(APPA)$ 8-K - Current report Filed: 2019-08-20 AccNo: 0001564590-19-032608 Size: 227 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接